Oncology Equipment Financing Options 2026: A Practical Guide

Choose the path below that matches your specific capital goal—whether you are upgrading a single diagnostic suite or launching a new radiation therapy center—to see the financing structures and rate expectations for 2026.

What to know

Financing heavy oncology hardware isn't a one-size-fits-all process. The decision between different funding vehicles often comes down to your practice's tax strategy, cash flow requirements, and the technological lifespan of the equipment in question. Before you sign a term sheet, you need to understand how the current lending environment affects your bottom line.

The Leasing vs. Purchasing Divide

For most private clinics, the primary tension lies in equipment-leasing-vs-buy. Purchasing requires a significant upfront cash outlay but grants you full asset ownership and potential Section 179 tax deductions. Leasing, conversely, preserves working capital—which is critical for practices needing to fund operational staff and facility overhead. In 2026, we are seeing a shift where practices prefer "Fair Market Value" (FMV) leases for rapidly evolving tech, allowing them to cycle out equipment every 3-5 years without the burden of disposal or obsolescence.

Specialized Considerations for High-Ticket Assets

When securing financing for major capital items, the lender’s risk assessment changes based on the equipment type.

• Radiotherapy Equipment: Lenders view these as mission-critical assets. Because these machines are essential to practice revenue, they are often easier to collateralize, but expect higher scrutiny on your facility’s patient volume projections and credentialing history.
• MRI and Diagnostic Imaging: These machines depreciate differently than linear accelerators. When researching mri-machine-financing, focus on "soft costs" (site preparation, shielding, and installation), which can add 20-30% to the total project cost. Many traditional lenders won't cover these soft costs, so you will need a lender who offers "total project" financing.

Key Indicators for 2026 Lenders

Regardless of the specific machine, lenders in 2026 are prioritizing practices with verifiable, stable patient flow and high reimbursement reliability. If you are a new practice, prepare to show a robust business plan, as lenders will look closely at your referral pipeline. If you are an established center, leverage your historical financial statements to negotiate lower interest rates on equipment leases.

Avoid the trap of focusing solely on the monthly payment. In the oncology space, equipment maintenance contracts (often costing tens of thousands annually) are distinct from financing. Ensure your financing package is decoupled from, or at least transparently integrated with, your service agreement. Miscalculating these maintenance costs is the most frequent reason practices find themselves "upside down" on an equipment lease three years into a contract.

Finally, be wary of aggressive "zero-down" offers. While appealing, they typically inflate the interest rate significantly over the life of the loan. In this market, putting 10-20% down usually results in a significantly lower total cost of ownership over the five-year horizon.